B

Biocartis

428 employees

Biocartis develops a diagnostics technology platform for the multiplexed detection of bio-analytes.

Investor insights

Sectors invested in

Sepsis1
Health Diagnostics1
Genetics1
Biotechnology1
Pharmaceutical1
Medical Device1
Health Care1
Molecular Pathology1
Genomic testing1
CAP1
Precision Medicine1
ThyroidPrint®1
Clinical Laboratory1
FNA1
Medical devices1
Molecular diagnostics1

Funding rounds participated in

$2.6M sweet spot round size

Most of their 2 investments are in rounds between $2M and $3.2M

Basic info

Industry

medical equipment manufacturing

Sectors

Biotechnology
Medical Device
Health Diagnostics
Oncology
Infectious Diseases
Molecular Diagnostics Solutions

Date founded

2007

Investments made

G

GeneproDX raised $3.2M on June 21, 2021

Investors: Biocartis

I

Immunexpress Inc. raised $2M on June 19, 2012

Investors: Biocartis

Funding rounds raised

Total raised

$96M

from 11 investors over 11 rounds

B

Biocartis raised $84M on September 4, 2014

Investors: Hitachi Chemical Diagnostics Inc.

B

Biocartis raised $40M on November 5, 2013

Investors: - and Wellcome Trust

B

Biocartis raised $45M on December 12, 2012

Investors: New Rhein Healthcare Investors LLC, Korys and -

B

Biocartis raised $96M on November 17, 2011

Investors: Wellcome Trust

B

Biocartis raised $40M on April 8, 2010

Investors: Advent Venture Partners and Aescap

B

Biocartis raised $15M on October 15, 2009

Investors: Advent Venture Partners and Aescap

FAQ